ClinicalTrials.gg
Drug

Nesvacumab clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2011

How each study uses Nesvacumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

nesvacumab (REGN910/ SAR307746)
2

Development codes

REGN910
1

Studies by the year they started

3 studies that test it; most in 2011 (1)

Studies that test Nesvacumab, by start year
YearStudies
20111
20121
20141

By phase

A phase 1/2 study counts in both.

Phase 1
3

Who runs them

Industry 3 · Other 0

Regeneron Pharmaceuticals (3)

Often tested with

Tested in the same studies.

REGN910-3 (1)

Studies

Open first, then newest update. How each study uses Nesvacumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

Codes

What other systems call Nesvacumab · ClinicalTrials.gg INT018396

  • UNII (FDA) WX8293WGLCNESVACUMABConfirmed FDA, Wikidata
  • Wikidata Q6998092NesvacumabConfirmed FDA, Wikidata
  • NCI Thesaurus C95712NesvacumabOne source FDA
  • DrugBank DB15330One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.